Biomerica Reports Third Quarter Fiscal 2025 Financial Results


IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the third quarter of fiscal 2025 ended February 28, 2025.

Original post:
Biomerica Reports Third Quarter Fiscal 2025 Financial Results

Related Posts